Coya Therapeutics, Inc. (NASDAQ:COYA) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock Announced: about US$11.1M · US$4.4 a share Buyers: Dr. Reddy’s Laboratories, Inc. ($10 million); Greenlight Capital ($1.1 million) Use of proceeds: Accelerate tech transfer and scale-up manufacturing of low dose IL-2 to support commercial readiness of COYA 302 | Jan 30, 2026 |
| Public offering of common stock Closed: US$23M raised · US$5.5 a share · Lucid Capital Markets +1 Dealers: Lucid Capital Markets (lead), Allele Capital Partners, LLC Use of proceeds: Working capital and general corporate purposes, including funding its clinical development plan | Oct 27, 2025 |